Compare NALWA SONS INV with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NALWA SONS INV vs INDOCO REMEDIES - Comparison Results

NALWA SONS INV     Change

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NALWA SONS INV INDOCO REMEDIES NALWA SONS INV/
INDOCO REMEDIES
 
P/E (TTM) x 14.1 54.3 25.9% View Chart
P/BV x 1.1 2.1 52.3% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 NALWA SONS INV   INDOCO REMEDIES
EQUITY SHARE DATA
    NALWA SONS INV
Mar-18
INDOCO REMEDIES
Mar-18
NALWA SONS INV/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,511317 476.1%   
Low Rs820178 460.5%   
Sales per share (Unadj.) Rs70.4113.1 62.3%  
Earnings per share (Unadj.) Rs16.54.5 369.4%  
Cash flow per share (Unadj.) Rs16.511.8 139.6%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs720.073.2 983.0%  
Shares outstanding (eoy) m5.1492.15 5.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x16.62.2 755.7%   
Avg P/E ratio x70.655.5 127.4%  
P/CF ratio (eoy) x70.621.0 336.9%  
Price / Book Value ratio x1.63.4 47.9%  
Dividend payout %022.4 0.0%   
Avg Mkt Cap Rs m5,99122,830 26.2%   
No. of employees `000NA5.5 0.1%   
Total wages/salary Rs m92,209 0.4%   
Avg. sales/employee Rs Th90,450.01,910.1 4,735.4%   
Avg. wages/employee Rs Th2,125.0405.0 524.7%   
Avg. net profit/employee Rs Th21,200.075.5 28,096.7%   
INCOME DATA
Net Sales Rs m36210,419 3.5%  
Other income Rs m147 2.3%   
Total revenues Rs m36310,466 3.5%   
Gross profit Rs m1041,349 7.7%  
Depreciation Rs m0677 0.0%   
Interest Rs m0235 0.1%   
Profit before tax Rs m105484 21.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2072 28.0%   
Profit after tax Rs m85412 20.6%  
Gross profit margin %28.812.9 222.6%  
Effective tax rate %19.315.0 129.1%   
Net profit margin %23.44.0 593.3%  
BALANCE SHEET DATA
Current assets Rs m1,2765,373 23.8%   
Current liabilities Rs m1194,157 2.9%   
Net working cap to sales %319.811.7 2,739.9%  
Current ratio x10.71.3 827.4%  
Inventory Days Days2068 29.3%  
Debtors Days Days2673 35.1%  
Net fixed assets Rs m06,244 0.0%   
Share capital Rs m51184 27.9%   
"Free" reserves Rs m3,6506,566 55.6%   
Net worth Rs m3,7016,750 54.8%   
Long term debt Rs m3271,233 26.5%   
Total assets Rs m4,42712,363 35.8%  
Interest coverage x351.33.1 11,486.4%   
Debt to equity ratio x0.10.2 48.3%  
Sales to assets ratio x0.10.8 9.7%   
Return on assets %1.95.2 36.8%  
Return on equity %2.36.1 37.6%  
Return on capital %2.69.0 29.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m03,762 0.0%   
Fx outflow Rs m01,143 0.0%   
Net fx Rs m02,619 0.0%   
CASH FLOW
From Operations Rs m2241,227 18.3%  
From Investments Rs m-129-1,360 9.5%  
From Financial Activity Rs m2-388 -0.5%  
Net Cashflow Rs m97-521 -18.6%  

Share Holding

Indian Promoters % 55.4 59.2 93.6%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 0.6 12.5 4.8%  
FIIs % 4.2 6.0 70.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 22.4 176.8%  
Shareholders   23,884 12,805 186.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NALWA SONS INV With:   MOTILAL OSWAL  FINOLEX INDUSTRIES  KITEX GARMENTS  INGERSOLL RAND  TIL  



Today's Market

Sensex Remains Rangebound; Bharti Airtel and ONGC Top Losers(12:30 pm)

Stock markets in India are presently trading flat. The BSE Sensex is trading down by 31 points and the NSE Nifty is trading down by 14 points.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

NALWA SONS INV Announces Quarterly Results (3QFY19); Net Profit Up 41.5% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, NALWA SONS INV has posted a net profit of Rs 11 m (up 41.5% YoY). Sales on the other hand came in at Rs 17 m (up 20.1% YoY). Read on for a complete analysis of NALWA SONS INV's quarterly results.

More Views on News

Most Popular

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

How the Modi Government is Helping My Top 7 Stocks(The 5 Minute Wrapup)

Nov 14, 2019

Recent reforms by the Modi government can give a big boost on your stocks, provided you buy the right ones.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NALWA SONS INV SHARE PRICE


Nov 21, 2019 03:37 PM

TRACK NALWA SONS INV

  • Track your investment in NALWA SONS INV with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NALWA SONS INV

NALWA SONS INV 8-QTR ANALYSIS

COMPARE NALWA SONS INV WITH

MARKET STATS